Profile

Jill Ohar, M.D.Wake Forest School of Medicine

Doctor Rating

No Rating Available
Why No Ratings?

Jill Ohar, M.D.

Professor,



Clinical Specialties

General Pulmonary Diseases, Lung Cancer, Chronic Obstructive Pulmonary Disease (COPD), Occupational Lung Disease

Contact Information

Department: 336-716-2011

Insurance Accepted »

Education & Training

  • B.S., Muhlenberg College , 1973
  • M.D., Med Coll Of Pennsylvania , 1977
  • Internship, Medicine, V.A. Hospital, 1979
  • Internship, Medicine, Med Coll Virginia Hosps, 1981
  • Fellowship, Medicine, VA Commonwlth U Med Coll of VA, 1985

Board Certifications

  • American Board of Internal Medicine, Internal Medicine - Critical Care Medicine
  • American Board of Internal Medicine, Internal Medicine - Internal Medicine
  • American Board of Internal Medicine, Internal Medicine - Pulmonary Disease

Memberships

  • Nat'L Board Of Medical Examine
  • Amer Coll Of Chest Physicians
  • Am Coll Of Physicians
  • American Thoracic Society

NPI Number

  • 1376526400
Jill Ohar, M.D.

Doctor Rating

No Rating Available
Why No Ratings?

Jill Ohar, M.D.

Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine
Center for Genomics and Personalized Medicine Research
Comprehensive Cancer Center
Center for Worker Health

Research Interests

genetics/genome, health services, research/outc

Contact Information

Academic: 336-716-4843 | Department: 336-716-2011

Recent Publications

Miles MC, Donohue JF, Ohar JA. Nebulized arformoterol: what is its place in the management of COPD?. Ther Adv Respir Dis. 2013;7(2):81-86.

Ohar JA, Crater G, Emmett A, Ferro T, Morris A, Raphiou I, Sriram P, Dransfield MT. Effects of fluticasone propionate/salmeterol combination 250/50mcg BID (ADVAIR DISKUS) vs. salmeterol 50mcg BID (SEREVENT DISKUS). Am J Respir Crit Care Med. 2013;187():A2439.

Pleasants R, Ohar JA. Comparison of different behavioral risk factor surveillance system methods on COPD epidemiological measures [abstract]. Am J Respir Crit Care Med. 2013;187():A3167.

Ohar JA, Edwards A, Howard S, Benshoff M, Donohue JF. COPD appears to lead to increased costs and enhance morbidity [abstract]. Am J Respir Crit Care Med. 2013;187():A5510.


Ohar J, Edwards A, Howard S, Benshoff M, Donohue J. Prevalence and impact of unrecognized COPD on elective surgery [abstract]. Eur Respir J. 2012;40(Suppl 56):620s-621s.

Ohar JA, Ruppel GL, Make BJ, Donohue JF. Restricted spirometry pattern in long term smokers--characteristics and association with heart disease [abstract]. Am J Respir Crit Care Med. 2012;185():A6043.

Miles MC, Donohue JF, Ohar JA. Combination therapy for COPD: emerging evidence from recent clinical trials. Clin Investig (Lond). 2011;1(6):879-890.

Ohar J, Fromer L, Donohue JF. Reconsidering sex-based stereotypes of COPD. Prim Care Respir J. 2011;20(4):370-378.

Ohar JA, Sadeghnejad A, Meyers DA, Donohue JF, Bleecker ER. Do symptoms predict COPD in smokers?. Chest. 2010;137(6):1345-1353.

Ohar JA, Hamilton RF Jr, Zheng S, Sadeghnejad A, Sterling DA, Xu J, Meyers DA, Bleecker ER, Holian A. COPD is associated with a macrophage scavenger receptor-1 gene sequence variation. Chest. 2010;137(5):1098-1107.

Sadeghnejad A, Ohar JA, Bleecker ER, Meyers D. Replication of an association of the interleukin-1 receptor antagonist gene with asthma in an adult urban admixed population [abstract]. Am J Respir Crit Care Med. 2010;181(1 Meeting Abstracts):A3877.

Ohar JA, Howard TD, Ampleford EJ, Bleecker ER, Meyers DA. Genome wide association study in mesothelioma [abstract]. Am J Respir Crit Care Med. 2010;181(1 Meeting Abstracts):A4340.

Ohar JA, Donohue JF. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD. Semin Respir Crit Care Med. 2010;31(3):321-333.

Sadeghnejad A, Ohar JA, Zheng SL, Sterling DA, Hawkins GA, Meyers DA, Bleecker ER. Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers. Respir Res. 2009;10():article 21.

Sadeghnejad A, Koppelman GH, Ohar JA, Postma DS, Bleecker ER, Meyers DA. Role of SERPINE2 in asthma and COPD [abstract]. Am J Respir Crit Care Med. 2009;179(Online Abstr Issue):A2741.

Ohar JA, Sadeghnejad A, Meyers DA, Bleecker ER. Symptoms poorly predict the presence of COPD in at-risk smokers [abstract]. Am J Respir Crit Care Med. 2009;179(Online Abstr Issue):A1471.

Schunemann HJ, Osborne M, Moss J, Manthous C, Wagner G, Sicilian L, Ohar J, McDermott S, Lucas L, Jaeschke R. An official American Thoracic Society policy statement: managing conflict of interest in professional societies. Am J Respir Crit Care Med. 2009;180(6):564-580.

Cazzola M, Hanania NA, Jones PW, Mahler DA, Make B, Ohar J, Rennard S. It's about time--directing our attention toward modifying the course of COPD. J Respir Med. 2008;102(Suppl 1):S37-S48.

Ohar JA, Holian A, Sadeghnejad A, Hamilton RF, Zheng SL, Xu J, Meyers DA, Bleecker ER. Polymorphisms in MSR1 gene affect macrophage function [abstract]. Am J Respir Crit Care Med. 2008;177(Online Abstr Issue):A503.

Sadeghnejad A, Ohar JA, Zheng SL, Hawkins GA, Meyers DA, Bleecker ER. ADAM33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers [abstract]. Am J Respir Crit Care Med. 2008;177(Online Abstr Issue):A504.

Ohar JA, Ampleford EJ, Howard SE, Sterling DA. Identification of a mesothelioma phenotype. Respir Med. 2007;101(3):503-509.

Sadeghnejad A, Meyers DA, Bleeker [sic] ER [Bleecker ER], Ohar JA. IL13 promoter polymorphism enhances the adverse effect of smoking on lung function [abstract]. Am J Respir Crit Care Med. 2007;175(Abstr Issue):A563.

Sadeghnejad A, Meyers DA, Bottai M, Sterling DA, Bleecker ER, Ohar JA. IL13 promoter polymorphism -1112C/T modulates the adverse effect of tobacco smoking on lung function. Am J Respir Crit Care Med. 2007;176(8):748-752.

Ampleford EJ, Ohar J. Mesothelioma: you do not have to work for it. Diagn Cytopathol. 2007;35(12):774-777.

Ohar J, McCallister J. Smoking trends have led to increased mortality: COPD in women, part 1: a review of recent trends. J Respir Dis. 2006;27(2):70-74.

Ohar J, McCallister J. Should sex differences affect the approach to treatment? COPD in women, part 2: treatment considerations. J Respir Dis. 2006;27(3):115-122.

Ohar JA, Ampleford EJ, Sterling DA, Bleecker ER, Meyers DA. ADAM33 is associated with COPD in a large US population [abstract]. In: American Thoracic Society International Conference Abstracts; 2006 May 19-24; San Diego (CA). 2006;():A620.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine

Clinical Specialties

General Pulmonary Diseases, Lung Cancer, Chronic Obstructive Pulmonary Disease (COPD), Occupational Lung Disease
Jill Ohar, M.D.
CP concern for questions/worries
5
CP efforts to include in decisions
5
CP explanations of prob/condition
5
CP spoke using clear language
5
Friendliness/courtesy of CP
5
Likelihood of recommending CP
5
Patients' confidence in CP
5
Time CP spent with patient
5
Wait time at clinic
5

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.